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Conclusion: This study indicates that both glucose 
metabolism measured by PET/CT and restriction measured by 
DW-MR are independent cellular phenomena in newly 
diagnosed esophageal cancer. Therefore, SUV with ADC 
values may have complementary roles as imaging biomarkers 
in the evaluation of survival and response to neoadjuvant 
treatment in esophageal cancer. 
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Purpose or Objective: To determine molecular subtypes of 
breast cancers using texture-feature-driven machine learning 
techniques on mammographic images. 
 
Material and Methods: We used mammograms of 61 ductal 
carcinomas (grade 2-3, median age 60, mean tumor size 
28mm). A physician defined a 100x100 ROI around tumors on 
mammographic images. Extraction of texture features was 
performed using three independent descriptors: Local Binary 
Patterns (LBP), Histogram of Oriented Gradients (HOG) and 
Gabor Filter (GF). Then, a supervised classification was 
applied using two independent classifiers: K-Nearest 
Neighbors (KNN) and Support Vector Machines (SVM) (both 
linear- and radial-type). Both classifiers were trained to 
identify the molecular subtype (Luminal A, Luminal B (Her2-), 
Luminal B (Her2+), Her2+, Basal Like and carcinoma in situ) 
using the first 38 mammograms. We assessed the accuracy of 
our machine learning technique using the last 23 
mammograms. 
 
 
Results: Accuracy of SVM-R classifier was 52% irrespective of 
the texture descriptor we used. SVM-L/KNN classifiers 
achieved an accuracy of 48/39, 35/30 and 21/35% for LBP, 
HOG and GF descriptors. When simplifying the classification 
problem to only two subtypes, Luminal A and Luminal B 
(Her2-), classifier accuracies astonishingly improved. SVM-R 
accuracy was 75% irrespective of the texture descriptor and 
SVM(L)/KNN accuracies were 38/75, 50/50 and 63/75% for 
LBP, HOG and GF. 
 
Conclusion: Our texture-feature-driven machine learning 
technique provides a reliable classification into molecular 
subtypes using mammographic images only. Accuracy 
improves when simplifying to only two subtypes. We expect 
even better accuracies by increasing the number of patients 
used for the training stage of our machine learning 
technique. 
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Purpose or Objective: Radiation induced lung toxicity (RILT) 
may occur in 5-20% of patients irradiated due to Non-Small 
Cell Lung Cancer (NSCLC) but may be asymptomatic during 
the course of radiotherapy (RTx). Computed tomography (CT) 
image changes induced by RILT present after 3-9 months 
since RTx, mostly as lung fibrosis. Early changes on lung 
tissue image, i.e. during treatment, are not possible to 
diagnose by the naked eye, but could be detect by computer-
assisted texture analysis. 
 
Material and Methods: Fifteen patients aged 63.7+/-6.4 
years, with NSCLC undergoing RTx were tested using CT 
before RTx and after receiving 40Gy of dose prescribed to 
PTV. Images were entered into a texture analysis program – 
MaZda® which extracted 284 texture parameters based on: 
signal intensity, variability of signal intensity, 
autocorrelation, direction of change, Fourier spectrum, 
Wavelet spectrum and repeatability of intensity change 
patterns. From every patient 10 regions of interest (ROIs) 
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were extracted (see image) at both timepoints from two 
sections of lung tissue – one that received the highest 
planned dose in healthy tissue and one that received low or 
no dose of RTx. Linear discriminant analysis (LDA) with 5-fold 
cross-validation and backward stepwise selection of variables 
was used to construct best classification models to separate 
irradiated from non-irradiated regions of the lung and 
differentiation of patients with RILT and without. 
 
 
 
Results: LDA based on seven parameters allowed for 
differentiation (area under the ROC curve 0.86) of regions of 
healthy tissue and regions from tumour’s site. The 7 variables 
were Wavelet-transform functions of different frequencies. 
However, despite those differences, CT-images from the 
40Gy timepoints differed significantly depending on the 
received dose. An LDA model based on six parameters (3 
autocorrelation functions, kurtosis and 2 wavelet function 
parameters) differentiated non-irradiated regions from 
irradiated ones – ROC AUC 0.89 (95%CI 0.75-1.00). 
Preliminary data from follow up showed that patients in 
whom RILT developed (N=7) could be differentiated from 
those free from complications (ROC 0.96 95%CI 0.89-1.00). 
However, parameters used in this LDA-based classifier relied 
on CT texture parameters extracted from both irradiated and 
non-irradiated ROIs, making ROI selection a crucial part of 
the texture analysis process. 
 
Conclusion: Texture of CT-scans contains enough information 
to detect RTx-induced changes, although the method may be 
affected by pretreatment differences, which necessitates a 
robust placement of ROIs for analysis. 
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Purpose or Objective: Textural analysis of lung tumors in 
PET or CT images is currently of interest in a number of 
publications e.g. to predict overall survival after 
radiotherapy. Given that tumor volume is a known 
independent predictor in radiotherapy of lung cancer, a 
textural feature must be volume independent to gain 
independent predictive power. Furthermore, the feature 
value should be stable against small variations in the 
delineated tumor volume. This study analyses how changes in 
PET based tumor volume and delineation affect different 
published textural features. 
 
Material and Methods: PET delineated tumors for 158 NSCLC 
patients were used to calculate textural features as proposed 
by Amadasun et al [IEEE Trans. Syst., Man, Cybern., Syst. 
1989]. Delineations of the tumors were made semi-
automatically based on EANM guidelines for VOI41 and VOI50 
(delineation at the 41% and 50% level of SUVmax). Additional 
smoothened delineations were made to resemble 
delineations made by humans. Furthermore, dilated versions 
of VOI41 were analyzed to determine the response of the 
textural features to large changes in delineation. Textural 
features are typically used to divide a patient population in 
two groups based on a given textural cut-value, e.g. the 
median value. Thus, the textural feature should preferably 
be stable towards small delineation variations in terms of 
patient classification. Such stability was tested using ROC 
curves, in which the initial delineation (VOI41) was used as 
ground truth classification based on the median value. 
Volume dependence of the textural features was assessed 
through the Spearman correlation coefficient.  
 
Results: Coarseness, busyness, contrast, and complexity were 
all confirmed to have a significant correlation with volume 
(absolute Spearman > 0.58). The figure shows coarseness’ 
ability to classify the patients consistently for different 
delineations. The large area under the ROC curve (almost 
unity) between VOI41, VOI50, and the smoothed VOI, shows 
that the patient classification is almost independent of small 
variations of delineation. The figure also shows how 
successive dilations of tumor volume reduce the area under 
the curve. Similar findings were observed for the textures 
busyness and contrast. A mathematical examination of the 
textural features provided an easy way to correct for the 
volume dependence of coarseness and contrast. Neither of 
these modified versions was found to have volume 
dependence (absolute Spearman < 0.22); while at the same 
time having the same stability characteristic as their original 
versions.  
 
Conclusion: All original textures had strong correlation with 
volume, which for PET delineation of lung tumors could be a 
confounding factor within a textural predictor. Through small 
changes to the original definition it is possible to make 
coarseness and contrast volume independent; a property 
which is needed for the features to be used as independent 
predictive factors. 
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